Using mathematical modeling as a resource in clinical trials
From MaRDI portal
Publication:814652
DOI10.3934/MBE.2005.2.421zbMATH Open1079.92037OpenAlexW2330473232WikidataQ51970316 ScholiaQ51970316MaRDI QIDQ814652FDOQ814652
Authors: Evans K. Afenya
Publication date: 7 February 2006
Published in: Mathematical Biosciences and Engineering (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/mbe.2005.2.421
Recommendations
Cited In (9)
- Mathematical modeling of bone marrow -- peripheral blood dynamics in the disease state based on current emerging paradigms. I
- On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach
- Title not available (Why is that?)
- Discrete mathematical models of an aggressive heterogeneous tumor growth with chemotherapy treatment
- Recovery of normal hemopoiesis in disseminated cancer therapy -- a model
- On an extension of a mathematical model for tumor anti-angiogenesis
- Title not available (Why is that?)
- Title not available (Why is that?)
- Mathematical modeling of bone marrow -- peripheral blood dynamics in the disease state based on current emerging paradigms. II
This page was built for publication: Using mathematical modeling as a resource in clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q814652)